Loading organizations...
Loading organizations...
Cancer immunotherapy and autoimmune disorder drug development company.
Biond Biologics has raised $32.0M across 2 funding rounds.
Biond Biologics has raised $32.0M in total across 2 funding rounds.
Biond Biologics has raised $32.0M in total across 2 funding rounds.
Biond Biologics's investors include Barak Ben-Eliezer, Harel Insurance Investments & Financial Services, Heritage Group, David Sidransky, Celgene, SBI JI Innovation Fund.
Biond Biologics has raised $32.0M across 2 funding rounds. Most recently, it raised $15.0M Series C in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 3, 2021 | $15.0M Series C | Barak Ben-Eliezer | Harel Insurance Investments & Financial Services, Heritage Group |
| Jan 8, 2019 | $17.0M Series B | Harel Insurance Investments & Financial Services, David Sidransky | Celgene, SBI JI Innovation Fund |